Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

25 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The New England journal of medicine
Vol/bind	375
Udgave nummer	21
Sider (fra-til)	2101-2102
Antal sider	2
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMc1610828#SA1
Status	Udgivet - 24 nov. 2016

Adgang til dokumentet

@article{e33a0073f3a941c7a103cbcb057576e0,

title = "Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis",

keywords = "Humans, Psoriasis, Severity of Illness Index, Treatment Outcome, Letter",

author = "Alexander Egeberg",

year = "2016",

month = nov,

day = "24",

doi = "10.1056/NEJMc1610828#SA1",

language = "English",

volume = "375",

pages = "2101--2102",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "21",

}

TY - JOUR

T1 - Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

AU - Egeberg, Alexander

PY - 2016/11/24

Y1 - 2016/11/24

KW - Humans

KW - Psoriasis

KW - Severity of Illness Index

KW - Treatment Outcome

KW - Letter

U2 - 10.1056/NEJMc1610828#SA1

DO - 10.1056/NEJMc1610828#SA1

M3 - Journal article

C2 - 27959739

SN - 0028-4793

VL - 375

SP - 2101

EP - 2102

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 21

ER -